Data from Genome-Wide siRNA Screen for Modulators of Cell Death Induced by Proteasome Inhibitor Bortezomib

Siquan Chen,Jonathan L. Blank,Theodore Peters,Xiaozhen J. Liu, David M. Rappoli,Michael D. Pickard,Saurabh Menon,Jie Yu, Denise L. Driscoll,Trupti Lingaraj, Anne L. Burkhardt, Wei Chen,Khristofer Garcia, Darshan S. Sappal,Jesse Gray,Paul Hales,Patrick J. Leroy, John Ringeling,Claudia Rabino, James J. Spelman, Jay P. Morgenstern,Eric S. Lightcap

crossref(2023)

引用 0|浏览4
暂无评分
摘要
Abstract

Multiple pathways have been proposed to explain how proteasome inhibition induces cell death, but mechanisms remain unclear. To approach this issue, we performed a genome-wide siRNA screen to evaluate the genetic determinants that confer sensitivity to bortezomib (Velcade (R); PS-341). This screen identified 100 genes whose knockdown affected lethality to bortezomib and to a structurally diverse set of other proteasome inhibitors. A comparison of three cell lines revealed that 39 of 100 genes were commonly linked to cell death. We causally linked bortezomib-induced cell death to the accumulation of ASF1B, Myc, ODC1, Noxa, BNIP3, Gadd45α, p-SMC1A, SREBF1, and p53. Our results suggest that proteasome inhibition promotes cell death primarily by dysregulating Myc and polyamines, interfering with protein translation, and disrupting essential DNA damage repair pathways, leading to programmed cell death. Cancer Res; 70(11); 4318–26. ©2010 AACR.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要